Vimarsana
Biggest News Aggregation in the World

Robert Uhl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Uhl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Uhl Today - Breaking & Trending Today

CSPAN2 Book TV September 2, 2013 - Vimarsana News

CSPAN2 Book TV September 2, 2013

Box upstairs and read it and go, holy cow you dont have holy cow experiences often, but when they come, its really a thrill for researchers, and that keeps us going. This book exists today because i gave in to one of those deep dark desires that lurks in the depths of the human soul. I refer to the desire to prove that your boss is full of bolonga. This happened in 2010. I was hired as a editor at American History magazine, and i immediately made a suggestion to the honcho of the place who just hired me. I said, the 150th anniversary of the civil war is coming up. Why dont we take a couple pag...

Celcuity Inc. (NASDAQ:CELC) Q2 2023 Earnings Call Transcript - Vimarsana News

Celcuity Inc. (NASDAQ:CELC) Q2 2023 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen, and welcome to the Celcuity Second Quarter 2023 Earnings Conference Call. At this time, all lines are in a listen-only mode.

Adamis Pharmaceuticals Announces Closing of $8.0 Million - Vimarsana News

Adamis Pharmaceuticals Announces Closing of $8.0 Million

SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today...

Celcuity Inc. Schedules Release of Second Quarter 2023 Financial Results and Webcast/Conference Call - Vimarsana News

Celcuity Inc. Schedules Release of Second Quarter 2023 Financial Results and Webcast/Conference Call

03.08.2023 - MINNEAPOLIS, Aug. 03, 2023 (GLOBE NEWSWIRE) - Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company focused on development of targeted therapies for oncology, today announced that it will release its financial results for the second ...

Sagimet Biosciences Announces Pricing of Upsized Initial - Vimarsana News

Sagimet Biosciences Announces Pricing of Upsized Initial

SAN MATEO, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company...